Skip to content

DR. STEFAN VANKRUNKELSVEN

Active
Private limited companyfounded 2001active for 25 yearsSchoterweg (C) 103, 3980 Tessenderlo-Ham, BelgiumKBO/BCE: BE 0474.413.142

From the official registers: KBO 25 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. STEFAN VANKRUNKELSVEN has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €500,926 and a net result of €116,787. Equity is growing by about 23% per year across the filed financial years. Its solvency ranks better than 95% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
DR. STEFAN VANKRUNKELSVENActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 27-03-2001 Normal situation
Legal form
Private limited company
Registered office
Schoterweg (C) 103, 3980 Tessenderlo-Ham
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.230.466.597 2430 Laakdal, since 15-03-2001
Financial year end
31 December
Peppol
Reachable since 21-01-2026
Company details

Who decides

Board
  • VANKRUNKELSVEN StefanDirector
Board & ownership

How it is doing

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€175,016
▼ 16.5%
Turnover
≈ €320,000
estimated
Profit
€116,787
▼ 13.5%
Equity
€500,926
▼ 26.8%
Total assets
€514,643
▼ 29.3%
2025 accounts filed 76 days late
Filed on 15-10-2026at the National Bank
Financials
Why 94raises riskLast filed accounts filed 76 days late; 3 of the last 3 latelowers riskSector: Human health activities (NACE 86)Founded in 2001Equity €500,926 (97.3% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 48% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 97.3% of total assets
Liquidity 59-20
short-term debt 2.6% · cash 7.2%
Profitability 97+5
return on assets 22.7%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: 0.1%▲ +0.1 percentage points vs 09-2026highest value
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity ample (current ratio 35.7, compared with 15.56 in 2024, above the usual 1.5; short-term debt: 2.6% and cash: 7.2% of total assets), and 2.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 36% on liquidity, 57% on profitability and 19% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
raises risk · Last filed accounts filed 76 days late; 3 of the last 3 late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Founded in 2001
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €500,926 (97.3% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 76 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-10-2026, 76 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
76 days late
2024
49 days late
2023
44 days late
2022
70 days late
2021
74 days late
2020
102 days late
2019
39 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 65 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 October (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Among the best 5% on solvencysector median 63.0% · 20,659 companies 97.3% View
  • Positive: 8 profitable years in a rowprofit 2025: €116,787 8 years View
  • Caution: Equity fell in 2025from €684,348 to €500,926 ▼ 26.8% View

Documents

Annual accounts at the NBB

All 25 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about DR. STEFAN VANKRUNKELSVEN

What is the company number of DR. STEFAN VANKRUNKELSVEN?
0474.413.142. In Belgium the VAT number is the company number with BE in front: BE 0474.413.142.
Where is DR. STEFAN VANKRUNKELSVEN based?
The registered office is at Schoterweg (C) 103, 3980 Tessenderlo-Ham.Company details
What does DR. STEFAN VANKRUNKELSVEN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. STEFAN VANKRUNKELSVEN?
Private limited company (BV).
When was DR. STEFAN VANKRUNKELSVEN founded?
On 27-03-2001.
Is DR. STEFAN VANKRUNKELSVEN still active?
Yes, DR. STEFAN VANKRUNKELSVEN is an active enterprise in the KBO register.
How many employees does DR. STEFAN VANKRUNKELSVEN have?
On average 1 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of DR. STEFAN VANKRUNKELSVEN?
≈ €320,000 in financial year 2025. Estimated from the gross margin of €175,016: probably between €250,000 and €390,000, based on 30 comparable companies, NACE 86210.
Is DR. STEFAN VANKRUNKELSVEN profitable?
In financial year 2025, DR. STEFAN VANKRUNKELSVEN made a profit of €116,787.
Where can I find the annual accounts of DR. STEFAN VANKRUNKELSVEN?
DR. STEFAN VANKRUNKELSVEN filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. STEFAN VANKRUNKELSVEN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR. STEFAN VANKRUNKELSVEN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure